Table 2.
Symptoms, medication for Covid-19 and physical examination findings of the study groups.
| Covid-19 (n = 30) | Covid-19 with Glutamine (n = 30) | p | |
|---|---|---|---|
| Symptoms | |||
| Fever | 25 (83.3) | 24 (80) | 0.901 |
| Cough | 22 (73.3) | 20 (66.6) | 0.784 |
| Dispne | 8 (26.7) | 9 (30) | 0.835 |
| Fatigue | 23 (76.7) | 21 (70) | 0.771 |
| Taste/smell abnormalities | 6 (20) | 3 (10) | 0.225 |
| Diarrhea | 7 (23.3) | 3 (10) | 0.283 |
| Medications | |||
| Hydroxychloroquine | 30 (100) | 30 (100) | 0.999 |
| Oseltamivir | 30 (100) | 28 (93.3) | 0.834 |
| Azithromycin | 15 (50) | 13 (43.3) | 0.796 |
| Moxifloxacin | 15 (50) | 17 (56.7) | 0.801 |
| Lopinavir/Ritonavir | 4 (13.3) | 3 (10) | 0.911 |
| Favipiravir | 2 (6.7) | 2 (6.7) | 0.999 |
| Other antibiotics | 2 (6.7) | 3 (6.7) | 0.913 |
| Physical examination findings | |||
| Fever (°C) | 38.1 ± 0.7 | 37.9 ± 1.2 | 0.198 |
| Systolic BP (mmHg) | 116 ± 15 | 117 ± 15 | 0.763 |
| Diastolic BP (mmHg) | 74 ± 9 | 71 ± 8 | 0.101 |
| Heart rate (/min.) | 89.9 ± 10.8 | 88.1 ± 11.9 | 0.527 |
| SO2 (%) | 93.1 ± 2.7 | 94.3 ± 4.3 | 0.225 |
| Respiratory rate (/min.) | 19.2 ± 3.3 | 17.8 ± 4.1 | 0.135 |
| Pneumonia Severity Index | 60.2 ± 15.9 | 56.2 ± 11.8 | 0.281 |
| Pneumonia Severity Index Grade | |||
| I | 0 | 0 | 0.354 |
| II | 25 (83.3) | 27 (90) | |
| III | 3 (10) | 3 (10) | |
| IV | 2 (6.7) | 0 | |
| V | 0 | 0 | |
BP; blood pressure, SO2; oxygen saturation.